Flagship Biosciences, Inc.

At Flagship Biosciences, we are committed to providing cutting-edge NGS solutions that enable comprehensive genomic profiling for oncology and hematologic malignancies. That’s why we offer both IDT xGen? Myeloid and Solid Tumor Panels and Archer? FusionPlex and VariantPlex Panels, ensuring robust, accurate biomarker insights for clinical research and drug development. ?? Why These Panels Matter in Precision Medicine ? IDT xGen? Myeloid & Solid Tumor Panels – Enable deep sequencing of key mutations across hematologic and solid tumor cancers, providing highly sensitive, targeted insights. ? Archer? FusionPlex & VariantPlex Panels – Utilize anchored multiplex PCR (AMP?) technology to detect gene fusions, SNVs, and CNVs, ensuring comprehensive variant detection. ?? How Flagship Leverages These Panels for Biomarker Analysis Our NGS lab integrates these best-in-class solutions to: ?? Identify clinically relevant genomic alterations for drug development ?? Provide high-confidence variant detection with best-in-class chemistry ?? Support companion diagnostic and translational research strategies By combining AI-powered digital pathology with advanced genomic profiling, Flagship Biosciences delivers a multi-modal approach to oncology research, helping biopharma partners make data-driven, confident decisions in clinical trials. Looking to enhance your oncology biomarker strategy? Let’s talk about how Flagship Biosciences’ NGS solutions can support your research. https://loom.ly/uHx9k60 #NGS #OncologyResearch #Biomarkers #PrecisionMedicine #Myeloid #SolidTumors #AIinPathology #ClinicalTrials

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide, but early detection, precision biomarkers, and advanced therapies are transforming patient outcomes. At Flagship Biosciences, we leverage AI-powered digital pathology and molecular profiling to provide quantitative, reproducible insights that drive better patient stratification and treatment decisions in CRC research. ?? How We Support Colorectal Cancer Research: ? AI-driven image analysis for precise quantification of CRC biomarkers ? NGS-based profiling for mutation detection in key genes (e.g., KRAS, BRAF, MSI status) ? Spatial biology solutions to understand the tumor microenvironment (TME) ? Multi-modal data integration for a more complete picture of disease progression By combining pathology and molecular insights, we help biopharma teams accelerate drug development and biomarker-driven therapies for CRC patients. ?? Early detection saves lives. Innovative science improves them. Let’s continue advancing colorectal cancer research together. Contact us to learn more: https://loom.ly/uHx9k60 #ColorectalCancerAwareness #CRCResearch #Biomarkers #AIinPathology #PrecisionMedicine #ClinicalTrials

On this Rare Disease Day, we reaffirm our commitment to supporting researchers, patients, and families in the fight against rare diseases like Duchenne Muscular Dystrophy (DMD)—a progressive and life-limiting condition affecting 1 in 3,500 male births worldwide. At Flagship Biosciences, we are proud to be the industry leader in DMD analysis, offering unparalleled expertise and proprietary technology to drive breakthroughs in understanding and treating this devastating disease. Our proprietary image analysis platform, developed specifically for DMD research, provides unmatched precision and insights by: - Quantifying histopathological changes in muscle tissue with unparalleled accuracy - Supporting biomarker discovery to aid in drug development - Delivering actionable data to accelerate clinical trials and improve therapeutic efficacy ?? Reach out today to learn how Flagship Biosciences can support your DMD or other rare disease research efforts. https://loom.ly/uHx9k60 #RareDiseaseDay #DuchenneMuscularDystrophy #PrecisionMedicine #ImageAnalysis #FlagshipBiosciences

Science is more than just data—it's curiosity, collaboration, and a shared commitment to making a difference. Here's a candid moment from our lab, where innovation happens every day. Whether it's analyzing tissue samples, optimizing our proprietary image analysis platforms, or supporting groundbreaking pharmaceutical research, our team is always working with one goal in mind: advancing precision medicine to improve patient outcomes. Stay tuned for more glimpses into the heart of Flagship, where science and passion meet! https://loom.ly/uHx9k60 #LifeAtFlagship #PrecisionMedicine #LabLife #InnovationInResearch

At Flagship Biosciences, staying at the forefront of tissue analysis means more than delivering exceptional results—it means continually evolving to meet the ever-changing needs of pharmaceutical research and diagnostics. ?? What Sets Us Apart? 1?? Continuous Innovation: We’re constantly developing new tools and methodologies to tackle emerging challenges in life sciences. 2?? Trend-Driven Insights: From spatial biology to advanced biomarker quantification, we stay ahead of the latest developments to keep you at the forefront of research. 3?? Custom Solutions: Our proprietary AI-powered platform is tailored to your specific project needs, ensuring flexibility and precision. 4?? Collaborative Approach: We partner closely with your team to align our work with your goals, timelines, and success metrics. From oncology breakthroughs to companion diagnostics (CDx), our cutting-edge image analysis services provide the actionable insights you need to drive impactful discoveries. ?? Let’s shape the future of science together—contact us today to learn more! https://loom.ly/uHx9k60 #ImageAnalysis #InnovationInResearch #PrecisionMedicine #PharmaResearch #FlagshipBiosciences

At Flagship Biosciences, our hearts beat for discovery, innovation, and the endless pursuit of knowledge. Science challenges us, inspires us, and connects us to a world of possibilities—making it our one true Valentine. Why do we love science? ?? It sparks curiosity: Science asks the big questions and dares us to explore the unknown. ?? It drives impact: From groundbreaking research to advancing precision medicine, science changes lives. ?? It unites us: Collaboration fuels discovery, bringing diverse minds together to solve the world’s toughest challenges. This Valentine’s Day, let’s celebrate the passion and dedication that scientists bring to their work every day. Whether in the lab, at the bench, or behind the data, science is the love that keeps us striving for more. What do you love most about science? Let us know in the comments! ???? #ValentinesDay #LoveScience #STEMPassion #FlagshipBiosciences

At Flagship Biosciences, we’re fortunate to have an incredible team of talented women scientists, innovators, and leaders who inspire us every day. From driving cutting-edge research to delivering impactful solutions for our clients, their contributions are invaluable in advancing the scientific frontier. Today, on the National Day of Women and Girls in Science, we celebrate their achievements and the vital role they play in shaping the future of science and medicine. Let’s continue to inspire and empower women and girls to pursue their dreams in STEM. Together, we can build a more inclusive and innovative world. https://loom.ly/uHx9k60 #WomenInScience #WomenInSTEM #STEMLeadership #FlagshipBiosciences

Flagship Biosciences supports pharmaceutical research teams in advancing precision medicine with our liquid biopsy cfDNA sequencing services—a powerful tool for accelerating companion diagnostic (CDx) development and beyond. ?? Why cfDNA Sequencing for Pharma? Non-invasive sampling: Simplify patient recruitment and longitudinal studies with a simple blood draw. Dynamic biomarker tracking: Monitor real-time genomic changes to inform drug development and optimize CDx strategies. Accelerate clinical trials: Identify actionable biomarkers and stratify patient populations with greater efficiency. ?? Our Comprehensive NGS Services Liquid biopsy is just one of the many next-generation sequencing (NGS) services we offer. Let us help you advance your pipeline with confidence. Contact us today to learn how Flagship Biosciences can support your pharma research and CDx initiatives. https://loom.ly/uHx9k60 #cfDNASequencing #LiquidBiopsy #PharmaResearch #NGS #FlagshipBiosciences

At Flagship Biosciences, we’re proud to leverage PhenoImager? and Opal? technology from Akoya Biosciences, Inc. to provide precise, high-plex analysis of biomarker expression and spatial biology. This versatile platform offers researchers the flexibility to choose from curated PhenoCode? Signature Panels or design a fully customized 8-plex Opal? Panel to meet their specific needs. Whatever your research goals, our team of skilled scientists is here to support you every step of the way. ?? Contact us to learn how we can help advance your biomarker research! https://loom.ly/uHx9k60 #PhenoImager #MultiplexIHC #SpatialBiology #PrecisionMedicine #FlagshipBiosciences

Today, on #WorldCancerDay, we stand united with the global community in the fight against cancer. At Flagship Biosciences, we’re dedicated to advancing precision medicine through innovative image analysis, NGS, Spatial Biology, and tissue-based solutions that empower scientists, clinicians, and drug developers to make meaningful progress in oncology. ?? Our mission is clear: to enable better patient outcomes, faster. Whether it’s through unlocking deeper insights from pathology or enhancing clinical trials, we are committed to being part of the solution. Contact us to learn more: https://loom.ly/uHx9k60 #WorldCancerDay2025 #PrecisionMedicine #CancerResearch #ImageAnalysis #FlagshipBiosciences